Literature DB >> 20694544

[Patients with malignancies of the oro- and hypopharynx as well as the larynx. Significance/importance of oncological aftercare consultation].

K Fritzsche1, K Breitenstein, D Esser.   

Abstract

The necessity of a long-time, closely monitored, well-structured, personal and time-consuming aftercare consultation is still discussed controversially. Based on the analysis of our oncological patients with tumours of the pharynx and larynx in the period from 1999-2000 we want to emphasize that after treatment is of vital importance. Besides the main focus of oncology on the early detection of recurrent tumours, distant metastases and second primary tumours as well as a fast interdisciplinary and mostly multimodal treatment planning, consultation is also a central point of reference and coordination site for rehabilitation, psycho-oncology and quality assurance of treatment. Last but not least consultation serves for purposes of continuous data collection and oncological epidemiology.

Entities:  

Mesh:

Year:  2010        PMID: 20694544     DOI: 10.1007/s00106-010-2154-2

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  14 in total

1.  [Tumor after-care: goals, results and concepts].

Authors:  I Haas
Journal:  Laryngorhinootologie       Date:  2000-11       Impact factor: 1.057

2.  [Incidence, latency, and prognosis of local and regional recurrences in patients with upper aerodigestive tract cancer treated by laser microsurgery: influence of initial tumor parameters].

Authors:  M C Jäckel; A Martin; W Steiner
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

3.  [Second primary carcinomas in the upper aerodigestive tract in different locations and age groups].

Authors:  K Schwager; A Nebel; G Baier; F Hoppe
Journal:  Laryngorhinootologie       Date:  2000-10       Impact factor: 1.057

4.  Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck.

Authors:  Panagiotis Balermpas; Markus Hambek; Oliver Seitz; Claus Rödel; Christian Weiss
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

5.  Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer.

Authors:  John P Kostrzewa; William P Lancaster; Tim A Iseli; Renee A Desmond; William R Carroll; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2010-02       Impact factor: 3.325

6.  Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx.

Authors:  Susan T Mayne; Brenda Cartmel; Victoria Kirsh; W Jarrard Goodwin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

7.  Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial.

Authors:  Fernando Rivera; Almudena García-Castaño; Noelia Vega; Maria Eugenia Vega-Villegas; Lourdes Gutiérrez-Sanz
Journal:  Expert Rev Anticancer Ther       Date:  2009-10       Impact factor: 4.512

8.  Determination of malnourishment in the head and neck cancer patient: assessment tools and nutrition education of radiation oncologists.

Authors:  Paul V DeCicco; Shahla M Wunderlich; Joana S Emmolo
Journal:  Support Care Cancer       Date:  2010-01-14       Impact factor: 3.603

9.  [Consumption and value of regular after care by patients with squamous cell carcinomas of the larynx, mouth cavity and pharynx].

Authors:  M Wolfensberger
Journal:  HNO       Date:  1988-01       Impact factor: 1.284

10.  Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy.

Authors:  Young Mi Seol; Bo Ran Kwon; Moo Kon Song; Young Jin Choi; Ho Jin Shin; Joo Seop Chung; Goon Jae Cho; Jin Chun Lee; Byung Joo Lee; Soo Geun Wang; Hak Jin Kim; Won Taek Kim; Seung Jang Kim; Eun Young Yun
Journal:  Acta Oncol       Date:  2010       Impact factor: 4.089

View more
  3 in total

1.  Incidence and localization of abnormal mucosa findings in patients consulting ENT outpatient clinics and data analysis of a cancer registry.

Authors:  J Löhler; A O H Gerstner; F Bootz; L E Walther
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-10       Impact factor: 2.503

2.  [Prevalence of abnormal mucosal findings in patients in HNO practices].

Authors:  J Löhler; A O H Gerstner; F Bootz; H Heinritz; A Fryen; G Fryen; N Holstein; A Lingg; J Kleeberg; W Langhoff; G Rösch; A Hanisch; E Schneeberg; D Heinrich; L E Walther
Journal:  HNO       Date:  2012-03       Impact factor: 1.284

3.  Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.

Authors:  Yonca Onbasi; Sebastian Lettmaier; Markus Hecht; Sabine Semrau; Heinrich Iro; Marco Kesting; Rainer Fietkau; Marlen Haderlein
Journal:  Strahlenther Onkol       Date:  2019-01-04       Impact factor: 3.621

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.